Consultation: Proposed regulations amending the Natural Health Products Regulations - Improving labelling for natural health products

Current status: Open

You are invited to provide feedback on Health Canada's regulatory proposal and related guidance to improve the labelling of natural health products.

This consultation is open for comments on June 26, 2021, and closing on September 4, 2021, at 11:59 p.m. Eastern Daylight Time (EDT).

Health Canada is committed to the health and safety of Canadians. Clear and legible labelling is a key component in communicating important information about the safe and proper use of natural health products, enabling Canadians to make an informed choice.

A recent audit by the Commissioner of the Environment and Sustainable Development (CESD) found that product label information, such as safety warnings, is difficult to read without magnification, which may lead to incorrect product use. This finding confirms that natural health product labels are hard to read, and supports the importance of this proposal.

The purpose of this consultation is to gather feedback on proposed improvements to natural health product labelling.

Join in: how to participate

Participate through Canada Gazette, Part I

You can provide your feedback on the proposed amendments to the Natural Health Products Regulations, through the Canada Gazette consultation. For more information, visit Canada Gazette, Part I.

Send us an email

You can contact us by email to:

Who is the focus of this consultation

We are seeking comments from:

Key items for comment

We want to amend the Natural Health Products Regulations to ensure that label information is clear, consistent and legible for consumers. This would align rules for natural health product labelling with the rules in international jurisdictions, such as the United States, the European Union, and Australia.

The proposed changes include:

We also want to gather feedback on the proposed Labelling Requirements for Natural Health Products guidance document. The guidance would further explain requirements for industry, including:

Lastly, we would like feedback on a consultation document on the introduction of risk-based evidence standards for homeopathic products, which would align the evidence standards for these products with those of other natural health products.

Contact us

Bureau of Program Policy, Risk Management and Stakeholder Engagement,
Natural and Non-prescription Health Products Directorate, HPFB, Health Canada
Email: hc.nnhpd.consultation-dpsnso.sc@canada.ca

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: